Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure

[1]  B. Löffler,et al.  Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan). , 1994, Circulation.

[2]  D. Webb,et al.  Contribution of endogenous generation of endothelin-1 to basal vascular tone , 1994, The Lancet.

[3]  J. Mcculloch,et al.  Effects on feline pial arterioles in situ of bosentan, a non-peptide endothelin receptor antagonist. , 1994, European journal of pharmacology.

[4]  K. Stoschitzky,et al.  Diminished Vascular Response to Inhibition of Endothelium‐Derived Nitric Oxide and Enhanced Vasoconstriction to Exogenously Administered Endothelin‐1 in Clinically Healthy Smokers , 1994, Circulation.

[5]  M. Kinoshita,et al.  Relation between endothelin-1 spillover in the lungs and pulmonary vascular resistance in patients with chronic heart failure. , 1994, Journal of the American College of Cardiology.

[6]  M. Fujishima,et al.  Naloxone augments sympathetic outflow induced by centrally administered endothelin in conscious rabbits. , 1994, The American journal of physiology.

[7]  W. Edwards,et al.  Endothelin in human congestive heart failure. , 1994, Circulation.

[8]  S. Ozaki,et al.  Clearance of circulating endothelin-1 by ETB receptors in rats. , 1994, Biochemical and biophysical research communications.

[9]  S. S. Sørensen,et al.  Systemic and renal effect of intravenous infusion of endothelin-1 in healthy human volunteers. , 1994, The American journal of physiology.

[10]  L. V. von Segesser,et al.  Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. , 1994, Circulation.

[11]  B. Löffler,et al.  Radioimmunological Determination of Endothelin Peptides in Human Plasma: A Methodological Approach , 1994 .

[12]  E. Weitzberg,et al.  Differences in vascular effects and removal of endothelin-1 in human lung, brain, and skeletal muscle. , 1993, Clinical physiology.

[13]  W. Neidhart,et al.  Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist , 1993, Nature.

[14]  C. Tondo,et al.  Nitric Oxide and Prostacyclin Influence Coronary Vasomotor Tone in Perfused Rabbit Heart and Modulate Endothelin‐1 Activity , 1993, Journal of cardiovascular pharmacology.

[15]  D. Stewart,et al.  Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. , 1993, The New England journal of medicine.

[16]  J. Vane,et al.  Formation by the endothelium of prostacyclin, nitric oxide and endothelin. , 1993, Journal of lipid mediators.

[17]  S. Douglas,et al.  Antihypertensive effects of the endothelin receptor antagonist BQ-123 in conscious spontaneously hypertensive rats. , 1993, Journal of cardiovascular pharmacology.

[18]  P. Binkley,et al.  Plasma Endothelin Correlates With the Extent of Pulmonary Hypertension in Patients With Chronic Congestive Heart Failure , 1992, Circulation.

[19]  A. Lerman,et al.  Endothelin Has Biological Actions at Pathophysiological Concentrations , 1991, Circulation.

[20]  M. van den Buuse,et al.  Sensitization of baroreceptor reflex by central endothelin in conscious rats. , 1991, The American journal of physiology.

[21]  T. Lüscher,et al.  Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor. , 1991, Circulation.

[22]  J. Vane,et al.  Regulatory functions of the vascular endothelium. , 1990, The New England journal of medicine.

[23]  H. Pieterman,et al.  Metabolism and Production of Angiotensin I in Different Vascular Beds in Subjects With Hypertension , 1990, Hypertension.

[24]  K. Ellenbogen,et al.  Arterial baroreflex abnormalities in heart failure. Reversal after orthotopic cardiac transplantation. , 1989, Circulation.

[25]  Sadao Kimura,et al.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.

[26]  M. Pfisterer,et al.  Arterial vasodilator, systemic and coronary hemodynamic effects of nisoldipine in congestive heart failure secondary to ischemic or dilated cardiomyopathy. , 1987, The American journal of cardiology.

[27]  B. Greenberg,et al.  Results of Long‐term Vasodilator Therapy in Patients with Refractory Congestive Heart Failure , 1981, Circulation.

[28]  I. Mefford.  Application of high performance liquid chromatography with electrochemical detection to neurochemical analysis: measurement of catecholamines, serotonin and metabolites in rat brain , 1981, Journal of Neuroscience Methods.

[29]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[30]  A. Kappelgaard,et al.  Measurement of angiotensin II in human plasma: technical modifications and practical experience. , 1976, Clinica chimica acta; international journal of clinical chemistry.